Shares of athletic apparel company Under Armour (NYSE:UAA) fell 18% in the afternoon session after President Trump announced "reciprocal tariffs" on all US imports, set at a minimum rate of 10%.
The Fund returned -0.89%, reflecting performance at the net asset value of class I Shares with all distributions reinvested, ...
Good morning and welcome to the ClearSign Technologies Fourth Quarter and Full Year 2024 Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's ...
Zoom in or out of the page as needed for optimal reading comfort. You can also use a pinch gesture to zoom on touch devices.
Q4 2024 Earnings Call Transcript April 1, 2025 Operator: All sites on hold. We do appreciate your patience in holding and ask ...
Cowboys EVP Stephen Jones gave a sobering update on 2 defensive standouts who suffered serious knee injuries late last season.
Despite the turmoil at the I.R.S., tax returns are still due on April 15. And, yes, there are still options for lowering last ...
Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure ...
6d
Bizcommunity on MSNThe Ctrack Quarterly Transport and Freight Index – Q1 2025The Ctrack Transport and Freight Index (Ctrack TFI) declined for eight consecutive months to reach an index level of 112.8 in ...
Research & Development Revenue of $30 Million Successful Results from the US Burn Validation Study On Track for Regulatory Submission ...
Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal ...
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for RosaceaEmrosi Initial Distribution Ongoing; First ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results